Market Closed -
Nyse
04:00:02 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
31.09
USD
|
+0.61%
|
|
+2.20%
|
+1.40%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
9,254
|
8,245
|
7,071
|
6,545
|
7,512
|
7,677
|
-
|
-
|
Enterprise Value (EV)
1 |
14,366
|
13,251
|
12,304
|
11,535
|
12,134
|
12,563
|
12,770
|
12,957
|
P/E ratio
|
26.8
x
|
51.9
x
|
16.9
x
|
15.5
x
|
30.7
x
|
22.9
x
|
21.1
x
|
22.7
x
|
Yield
|
6.26%
|
7.38%
|
9.06%
|
9.59%
|
8.74%
|
8.62%
|
8.64%
|
8.69%
|
Capitalization / Revenue
|
11.7
x
|
11.1
x
|
7.76
x
|
8.91
x
|
9.27
x
|
9.25
x
|
8.7
x
|
8.56
x
|
EV / Revenue
|
18.2
x
|
17.9
x
|
13.5
x
|
15.7
x
|
15
x
|
15.1
x
|
14.5
x
|
14.4
x
|
EV / EBITDA
|
16.8
x
|
16.2
x
|
12.5
x
|
14.5
x
|
14.2
x
|
13.6
x
|
12.9
x
|
12.5
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2.27
x
|
-
|
1.81
x
|
1.72
x
|
2.1
x
|
1.85
x
|
1.83
x
|
1.8
x
|
Nbr of stocks (in thousands)
|
218,502
|
227,004
|
238,974
|
234,183
|
244,994
|
246,934
|
-
|
-
|
Reference price
2 |
42.35
|
36.32
|
29.59
|
27.95
|
30.66
|
31.09
|
31.09
|
31.09
|
Announcement Date
|
2/5/20
|
2/4/21
|
2/2/22
|
2/2/23
|
2/7/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
791.2
|
740.8
|
910.7
|
734.2
|
810
|
830.3
|
882.9
|
896.8
|
EBITDA
1 |
856
|
820.2
|
985.9
|
793.3
|
853.2
|
923.7
|
991.2
|
1,036
|
EBIT
1 |
551.7
|
490.3
|
643.9
|
460.9
|
533.5
|
584.3
|
644.1
|
675.3
|
Operating Margin
|
69.74%
|
66.18%
|
70.7%
|
62.78%
|
65.87%
|
70.38%
|
72.96%
|
75.3%
|
Earnings before Tax (EBT)
1 |
343.8
|
162.3
|
416.1
|
436.1
|
255.6
|
346.2
|
396
|
399.6
|
Net income
1 |
341.1
|
159.3
|
416.7
|
426.9
|
242.2
|
346.2
|
380.3
|
398.6
|
Net margin
|
43.12%
|
21.51%
|
45.76%
|
58.15%
|
29.9%
|
41.7%
|
43.08%
|
44.45%
|
EPS
2 |
1.580
|
0.7000
|
1.750
|
1.800
|
1.000
|
1.359
|
1.473
|
1.369
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
2.650
|
2.680
|
2.680
|
2.680
|
2.680
|
2.680
|
2.687
|
2.702
|
Announcement Date
|
2/5/20
|
2/4/21
|
2/2/22
|
2/2/23
|
2/7/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
243.6
|
214.3
|
213.3
|
207.5
|
203.2
|
110.1
|
185.1
|
215
|
205.9
|
204
|
199.9
|
204.7
|
210.6
|
215
|
215.6
|
EBITDA
1 |
263
|
228.8
|
229.3
|
222.2
|
217
|
124.8
|
193.7
|
224.1
|
217.9
|
217.6
|
219.6
|
225.4
|
232.5
|
239.1
|
241.4
|
EBIT
1 |
176.9
|
143.5
|
146.6
|
139
|
134.3
|
41.11
|
75.58
|
142.1
|
137.1
|
141.9
|
138.2
|
143.3
|
148.9
|
154
|
153
|
Operating Margin
|
72.64%
|
66.97%
|
68.7%
|
66.95%
|
66.09%
|
37.32%
|
40.83%
|
66.08%
|
66.56%
|
69.56%
|
69.11%
|
70%
|
70.69%
|
71.62%
|
70.97%
|
Earnings before Tax (EBT)
1 |
142.3
|
33.71
|
194.8
|
91.25
|
102.1
|
47.99
|
34.72
|
62.08
|
97.01
|
61.82
|
79.99
|
84.75
|
90.02
|
91.65
|
91.8
|
Net income
1 |
138.9
|
33.29
|
189.6
|
89.47
|
102.3
|
45.58
|
35.94
|
59.86
|
91.38
|
55
|
79.9
|
85.31
|
89.61
|
92.64
|
90.05
|
Net margin
|
57.04%
|
15.53%
|
88.87%
|
43.11%
|
50.33%
|
41.38%
|
19.42%
|
27.84%
|
44.38%
|
26.96%
|
39.97%
|
41.67%
|
42.55%
|
43.09%
|
41.77%
|
EPS
2 |
0.5800
|
0.1400
|
0.7900
|
0.3800
|
0.4300
|
0.1900
|
0.1500
|
0.2500
|
0.3700
|
0.2200
|
0.3137
|
0.3315
|
0.3502
|
0.3622
|
0.3399
|
Dividend per Share
2 |
0.6700
|
0.6700
|
0.6700
|
0.6700
|
0.6700
|
0.6700
|
0.6700
|
0.6700
|
0.6700
|
0.6700
|
0.6700
|
0.6700
|
0.6700
|
0.6700
|
0.6734
|
Announcement Date
|
11/4/21
|
2/2/22
|
5/2/22
|
8/1/22
|
11/2/22
|
2/2/23
|
5/2/23
|
8/2/23
|
11/2/23
|
2/7/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
5,112
|
5,006
|
5,233
|
4,990
|
4,623
|
4,886
|
5,093
|
5,280
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
5.972
x
|
6.103
x
|
5.308
x
|
6.289
x
|
5.418
x
|
5.29
x
|
5.138
x
|
5.098
x
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
10.3%
|
3.99%
|
10.8%
|
11.4%
|
6.74%
|
9.06%
|
10.3%
|
11.4%
|
ROA (Net income/ Total Assets)
|
4.25%
|
-
|
-
|
-
|
2.62%
|
3.23%
|
3.41%
|
3.58%
|
Assets
1 |
8,019
|
-
|
-
|
-
|
9,261
|
10,719
|
11,148
|
11,135
|
Book Value Per Share
2 |
18.60
|
-
|
16.30
|
16.20
|
14.60
|
16.80
|
17.00
|
17.30
|
Cash Flow per Share
2 |
-
|
-
|
2.960
|
2.560
|
-
|
2.840
|
3.010
|
3.130
|
Capex
1 |
-
|
-
|
-
|
-
|
-
|
11.9
|
12.5
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
1.43%
|
1.42%
|
-
|
Announcement Date
|
2/5/20
|
2/4/21
|
2/2/22
|
2/2/23
|
2/7/24
|
-
|
-
|
-
|
Last Close Price
31.09
USD Average target price
32.92
USD Spread / Average Target +5.90% Consensus |
1st Jan change
|
Capi.
|
---|
| +1.40% | 7.68B | | +4.62% | 55.76B | | -11.72% | 17.72B | | -5.05% | 13.23B | | -16.54% | 5.39B | | +8.62% | 3.28B | | -2.31% | 3.23B | | -5.42% | 3.06B | | -8.15% | 2.73B | | +12.61% | 2.73B |
Healthcare REITs
|